Phase III Option definition

Phase III Option has the meaning set forth in section 2.10 (b).
Sample 1Sample 2Sample 3
Phase III Option is defined in Section 35.01.
Sample 1

Examples of Phase III Option in a sentence

  • Upon the earlier of exercise of the Phase III Option or the expiration of this Agreement without the University having exercised the Phase III Option, the University shall pay to City Investors a true-up option payment in the amount of $2,413,000 (the “True-up Option Payment”).

  • If the University or its permitted designee exercises the Phase III Option within the Phase III Option Term, City Investors and the University or its permitted designee shall negotiate in good faith and with reasonable diligence to finalize definitive documents for the development of the Phase III Property, based on substantially the following terms and conditions: 7.1 Phase III Ground Lease.

  • Notwithstanding the foregoing, the University shall be entitled to assign its rights hereunder to a non-profit organization simultaneously with the exercise of the Phase III Option to effect a ground lease/building lease structure similar to the ground lease and building lease under the Phase II Option Agreement, and ground rent under the Phase III Ground Lease would be subject to subordination to bond financing in the same general terms as the Phase II Ground Lease.

  • The Food Aid Quality Review (FAQR) team submitted a series of Phase III Option Year 2 deliverables to the United States Agency for International Development’s Bureau for Humanitarian Assistance (USAID/BHA) in the second quarter of FY 2021.

  • The University may exercise the Phase III Option at any time during the Phase III Option Term by delivering written notice of exercise to City Investors.

  • Exercising of Phases II – Option Period 1 and Phase III- Option Period II is at the sole discretion of the Government.Multiple awards are anticipated.

  • The University may exercise the Phase III Option only as to the entire Phase III Property.

  • If the Phase III Option is exercised, development of the Phase III Property shall be consistent with the applicable portions of the Phase III Property Master Plan Report prepared by Perkins + Will dated March 27, 2009 and attached as an exhibit to the First Amendment to the Prior Phase III Option Agreement and the site plan attached hereto as Exhibit D (collectively the “Master Plan”).

  • City Investors also agrees to exercise such termination rights at the request of the University immediately following the exercise of the Phase III Option.

  • If this Agreement terminates or expires without the University having exercised the Phase III Option (including a termination effected by written notice of termination given to City Investors by the University, which the University may do at any time, or the expiration of the Phase III Option Term), the University shall pay to City Investors a deferred option payment in the amount of $4,250,000 (the “Deferred Option Payment”).

Related to Phase III Option

  • 3(i) Option means an Option granted pursuant to Section 3(i) of the Ordinance to any person who is Non- Employee.

  • Top-Up Option has the meaning set forth in Section 1.04(a).

  • Development Milestone Event has the meaning set forth in Section 7.2.1.

  • Shoe Option means the Initial Purchasers’ option to purchase up to seventy five million dollars ($75,000,000) aggregate principal amount of additional Notes as provided for in the Purchase Agreement.

  • Vested Option means any Option, which has already been vested according to the Vesting Dates.

  • Performance Option means an Incentive Stock Option or Nonqualified Stock Option, the grant of which or the exercisability of all or a portion of which is contingent upon the attainment of specified Performance Measures within a specified Performance Period.

  • Phase III Study means a human clinical trial that is prospectively designed to demonstrate statistically whether a product is safe and effective for use in humans in a manner sufficient to obtain regulatory approval to market such product in patients having the disease or condition being studied as described in 21 C.F.R. § 312.21(c) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Grant Year has the same meaning as in subclause 1(1) of Schedule 1 of HESA;

  • Development Milestone is defined in Section 5.3.

  • Milestone Event has the meaning set forth in Section 8.2.1.

  • Option Term means a period, if any, through which this Agreement may be or has been extended by the JBE.

  • Phase III means human clinical trials, the principal purpose of which is to establish substantial evidence of both safety and efficacy in patients with the disease or condition being studied, as more fully defined in 21 C.F.R. §312.21(c) or similar clinical study in a country other than the United States. Phase III shall also include any other human clinical trial intended to serve as a pivotal trial to support the submission of an application for regulatory approval.

  • Option Period means the period during which an Option may be exercised.

  • Vested Options means the Options that have vested in accordance with Section 2.2 of this Agreement.

  • Extension Option shall have the meaning set forth in Section 2.5(c) hereof.

  • Covered Call Option means an exchange traded option entitling the holder, upon timely exercise and payment of the exercise price, as specified therein, to purchase from the writer thereof the specified underlying Securities (excluding Futures Contracts) which are owned by the writer thereof and subject to appropriate restrictions.

  • Stock Index Option means an exchange traded option entitling the holder, upon timely exercise, to receive an amount of cash determined by reference to the difference between the exercise price and the value of the index on the date of exercise.

  • Unvested Option means an Option in respect of which the relevant Vesting Conditions have not been satisfied and as such, the Option Grantee has not become eligible to exercise the Option.

  • Phase III Trial means a Clinical Trial of an investigational product in subjects that incorporates accepted endpoints for confirmation of statistical significance of efficacy and safety with the aim to generate data and results that can be submitted to obtain Regulatory Approval as described in 21 C.F.R. 312.21(c), or a comparable Clinical Trial prescribed by the relevant Regulatory Authority in a country other than the United States.

  • Director Option means an Option granted pursuant to Section 6.

  • Option Exercise Period has the meaning set forth in Section 6.4.

  • Phase II Study means a human clinical trial, for which the primary endpoints include a determination of dose ranges and/or a preliminary determination of efficacy in patients being studied as described in 21 C.F.R. § 312.21(b) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Development Milestone Payment shall have the meaning set forth in Section 9.2(a).

  • Employee Option means an Option granted pursuant to Section 5.